ARCHIVES

Rituximab Prolonged Survival Of CLL In Phase III Study

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005

MSKCC Wins Zoning Request For New Labs.

February 8, 2002

Congressional subcommittee criticizes NIH for lax conflict of interest policies. NIH Director Zerhouni promises change. The subcommittee has asked several NCI officials to testify at another hearing next week.

May 14, 2004

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000